alirocumab
0 sources
alirocumab
Summary
alirocumab is a type of chemical entity[1]. alirocumab ranks in the top 5% of type_of_chemical_entity entities by monthly Wikipedia readership (83 views/month).[2]
Key Facts
- alirocumab's instance of is recorded as type of chemical entity[3].
- alirocumab's CAS Registry Number is recorded as 1245916-14-6[4].
- alirocumab's ATC code is recorded as C10AX14[5].
- alirocumab's chemical formula is recorded as C₆₄₇₂H₉₉₉₆N₁₇₃₆O₂₀₃₂S₄₂[6].
- alirocumab's subclass of is recorded as chemical compound[7].
- alirocumab's has use is recorded as medication[8].
- alirocumab's MeSH descriptor ID is recorded as C571059[9].
- alirocumab's ChEMBL ID is recorded as CHEMBL2109540[10].
- alirocumab's Guide to Pharmacology Ligand ID is recorded as 6744[11].
- alirocumab's Freebase ID is recorded as /m/0js_wl_[12].
- alirocumab's UNII is recorded as PP0SHH6V16[13].
- alirocumab's DrugBank ID is recorded as DB09302[14].
- alirocumab's has characteristic is recorded as biopharmaceutical[15].
- alirocumab's HSDB ID is recorded as 8280[16].
- alirocumab's NDF-RT ID is recorded as N0000191810[17].
- alirocumab's medical condition treated is recorded as lipedema[18].
- alirocumab's medical condition treated is recorded as arteriosclerosis[19].
- alirocumab's medical condition treated is recorded as hyperlipoproteinemia type V[20].
- alirocumab's World Health Organisation international non-proprietary name is recorded as {'lang': 'en', 'text': 'alirocumab'}[21].
- alirocumab's subject has role is recorded as monoclonal antibody[22].
- alirocumab's RxNorm CUI is recorded as 1659152[23].
- alirocumab's World Health Organisation international non-proprietary name numeric ID is recorded as 9620[24].
- alirocumab's active ingredient in is recorded as Praluent[25].
- alirocumab's defined daily dose is recorded as {'unit': 'Q3241121', 'amount': '+5.4'}[26].
- alirocumab's Microsoft Academic ID is recorded as 2780902209[27].
Why It Matters
alirocumab ranks in the top 5% of type_of_chemical_entity entities by monthly Wikipedia readership (83 views/month).[2] alirocumab has Wikipedia articles in 14 language editions, a strong signal of global cultural recognition.[28] alirocumab is known by 3 alternative names across languages and contexts.[29]